Robotic Oesophageal Cancer Surgeon London and Gastric Cancer Surgeon London at The Royal Marsden & Institute of Cancer Research, the world's oldest cancer centre and largest comprehensive cancer institution in Europe. Oxford University graduate with distinction and academic prize scholarship with 25 years NHS experience. Co-founder International Upper GI Robotic Association, UGIRA. Established first Da Vinci Xi Robotic program for thoracic Oesophageal & Gastric Cancer in the UK in 2015 at RMH. Lead most comprehensive Minimally Invasive UGI Cancer surgery service in London. Joint lead Investigator, ICONIC trial, the first Perioperative immunotherapy trial for OG cancer. Mentor at Digital Health London. Advisory Consultant, Medtronic PLC: largest global medical device company. UGI Lead Royal College of Surgeons of England, Robotic & Digital Surgery initiative, RADAR. Co-founder AnnoLens AI winner of prestigious 2020 Innovate UK award for visual operative AI. Member NHS England London Clinical Senate, advised Health Sec on Oriel relocation masterplan. Member Clinical Advisory Group, Chief People Officer NHS. Interested in health policy, biotechnology, Robotics and AI. Involvement in high level UK policy formulation & strategy. Health and Fintech investor. Specialist Advisory Member, International Cancer Benchmarking Partnership aiming to reduce inequality in cancer outcomes globally. Commissioner for Lancet Oncology Comprehensive Commission for Cancer in The Commonwealth Editor: Surgical Oncology: Oxford University Press Gastric & Oesophageal Surgery: Oxford University Press, Clinical Surgery: Elsevier https://www.iwantgreatcare.org/doctors/asif-chaudry https://www.royalmarsden.nhs.uk/our-consultants-units-and-wards/consultant-directory/mr-m-asif-chaudry